… sole risk factor for EGFR mutated lung cancer (OR for women … EGFR mutated NSCLC but
not with EGFR WT lung cancer (… polymorphisms and lung cancer with EGFR mutation. There …

… mutations. The overall frequency of EGFR mutations in lung adenocarcinomas in this West
… , whereas KRAS mutation frequency is higher than in any population described to date. …

… This study analyzed 61 cases of EGFR mutation positive lung adenocarcinoma using next-…
mutations and investigated clinical implication of compound EGFR mutations. Compound …

… a patient with EGFR-mutant, gefitinib-responsive, advanced non–small-cell lung cancer who
… The DNA sequence of the EGFR gene in his tumor biopsy specimen at relapse revealed the …

… , EGFR mutations of patients with lung adenocarcinoma often go … significance of EGFR
mutations in lung adenocarcinoma and … study, EGFR mutations in lung adenocarcinoma patients …

… Janne has filed a patent claim for the analysis of EGFR mutations in lung cancer, and has
received honoraria (<$10,000) from Astra Zeneca and Roche and other remuneration from …

… for lung cancer patients with an EGFR mutation. In this review, we describe the features
of KRAS mutations in lung cancer and contrast these with the features of EGFR mutations. …

… The discovery of EGFR tyrosine kinase inhibitors (TKI) was regarded as a landmark finding
… of lung cancer [5–8]. Targeted EGFR-TKI first-line treatment of sensitizing EGFR mutations …

… In China, it is also the most common cancer and leading cause of cancer-related … (EGFR)
mutations. NSCLC harboring EGFR mutations constitutes about 10–20% of all lung cancer …

… the tyrosine kinase of EGFR, which competitively inhibits ATP-… lung adenocarcinoma with
EGFRmutations (overall response rate [ORR], 71.2%), but not for that without EGFR-mutations (…